Alfaris, Nasreen

Definition and diagnostic criteria of clinical obesity

Rubino, F., Cummings, D. E., Eckel, R. H., Cohen, R. V., Wilding, J. P. H., Brown, W. A., Stanford, F. C., Batterham, R. L., Farooqi, I. S., Farpour-Lambert, N. J., et al. (2025) · The Lancet Diabetes & Endocrinology

Obesity and Health PracticesObesity, Physical Activity, Diet

Cited by 1,811

GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review

Alfaris, N., Waldrop, S., Johnson, V., Boaventura, B., Kendrick, K., & Stanford, F. C. (2024) · EClinicalMedicine

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 224

Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment

Wharton, S., Aronne, L. J., Stefanski, A., Alfaris, N. F., Ciudin, A., Yokote, K., Halpern, B., Shukla, A. P., Zhou, C., Macpherson, L., et al. (2025) · New England Journal of Medicine

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 189

Effects of a 2‐year behavioral weight loss intervention on sleep and mood in obese individuals treated in primary care practice

Alfaris, N., Wadden, T. A., Sarwer, D. B., Diwald, L., Volger, S., Hong, P., Baxely, A., Minnick, A. M., Vetter, M. L., Berkowitz, R. I., et al. (2015) · Obesity

Sleep and related disordersObstructive Sleep Apnea Research

Cited by 57

Effects of addictive-like eating behaviors on weight loss with behavioral obesity treatment

Chao, A. M., Wadden, T. A., Tronieri, J. S., Pearl, R. L., Alamuddin, N., Bakizada, Z. M., Pinkasavage, E., Leonard, S. M., Alfaris, N., & Berkowitz, R. I. (2019) · Journal of Behavioral Medicine

Eating Disorders and BehaviorsNutrition, Health and Food Behavior

Cited by 48

Short‐ and Long‐Term Changes in Health‐Related Quality of Life with Weight Loss: Results from a Randomized Controlled Trial

Pearl, R. L., Wadden, T. A., Tronieri, J. S., Berkowitz, R. I., Chao, A. M., Alamuddin, N., Leonard, S. M., Carvajal, R., Bakizada, Z. M., Pinkasavage, E., et al. (2018) · Obesity

Pharmacology and Obesity TreatmentObesity, Physical Activity, Diet

Cited by 38

Combination phentermine and topiramate extended release in the management of obesity.

Alfaris, N., Minnick, A. M., Hopkins, C. M., Berkowitz, R. I., & Wadden, T. A. (2015) · Expert Opinion on Pharmacotherapy

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 38

Clinical effectiveness of Liraglutide 3.0 mg and impact of weight loss in improving obesity‐related comorbid conditions in King Fahad Medical City, Kingdom of Saudi Arabia: A real‐world experience

Alshehri, A., AlFaris, N., Al Qahtani, A. M., Shams, M., & Yahia, M. (2023) · Clinical Obesity

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 11